|
[1] NORDENSTEDT H, WHITE DL, EL-SERAG HB. The changing pattern of epidemiology in hepatocellular carcinoma[J]. Digest Liver Dis, 2010, 42 (2) :s206-s214.
|
|
[2] CONG WM, BU H, CHEN J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer:2015 update[J].World J Gastroentero, 2016, 22 (42) :9279-9287.
|
|
[3] YE JZ, YAN SM, YUAN CL, et al. GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells[J].J Cancer, 2018, 9 (2) :415-423.
|
|
[4] LIU B, LUO Q, WANG HL. Application of radiofrequency ablation in liver cancer treatment[J]. Hebei Med J, 2017, 39 (6) :926-929. (in Chinese) 刘波, 罗强, 王洪林.射频消融在肝癌治疗中的应用进展[J].河北医药, 2017, 39 (6) :926-929.
|
|
[5] ZHU XB, HUANG S. Application of fusion imaging magnetic navigation system in local ablation of hepatocellular carcinoma chinese[J]. Chin J Med Offic, 2016, 44 (2) :213-215. (in Chinese) 朱鑫彪, 黄枢.融合成像导航系统在肝癌局部消融中应用[J].临床军医杂志, 2016, 44 (2) :213-215.
|
|
[6] Health and Family Planning Commission of the People's Republic of China. Standardization of diagnosis and treatment for hepatocellularcarcinoma (2017 edition) [J]. J Chin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
|
|
[7] III ABB, D’ANGELICA MI, ABBOTT DE, et al. Hepatobiliary Cancers, Version 1. 2017:Featured Updates to the NCCN Guidelines[J]. J Natl Compr Canc Netw, 2017, 15 (5) :563-573.
|
|
[8] CHEN MS, CHEN MH. Guidelines for radiofrequency ablation therapy of liver cancer[J]. J Clini Hepatol, 2011, 27 (3) :236-238 (in Chinese) 陈敏山, 陈敏华.肝癌射频消融治疗规范的专家共识[J].临床肝胆病杂志, 2011, 27 (3) :236-238.
|
|
[9] HU XW, DING TL, HONG ZX. Partial hepatectomy combined with radiofrequency ablation in the treatment of primary liver cancer[J].Trauma Crit Med, 2018, 6 (4) :226-227, 230. (in Chinese) 胡雄伟, 丁同领, 洪智贤.部分肝切除术联合射频消融术治疗原发性肝癌疗效分析[J].创伤与急危重病医学, 2018, 6 (4) :226-227, 230.
|
|
[10] ZENG LJ, ZOU JZ. High-intensity focused ultrasound in the clinical application of liver cancer[J]. J Mod Med Health, 2016, 32 (10) :1490-1492. (in Chinese) 曾林静, 邹建中.高强度聚焦超声在肝癌治疗中的临床应用[J].现代医药卫生, 2016, 32 (10) :1490-1492.
|
|
[11] DU L, HOU LC, ZHANG LQ, et al. Application of microwave ablation in treatment of solid space-occupying lesions in the liver[J]. J Clin Hepatol, 2017, 33 (10) :2030-2034. (in Chinese) 杜磊, 侯立朝, 张灵强, 等.微波消融在肝脏实性占位病变治疗中的应用[J].临床肝胆病杂志, 2017, 33 (10) :2030-2034.
|
|
[12] YAN JZ, WENG H, ZHANG C. Clinical effect and safety of percutaneous radiofrequency ablation versus microwave ablation in treatment of hepatocellular carcinoma:A Meta-analysis[J]. J Clin Hepatol, 2018, 34 (5) :1025-1035. (in Chinese) 鄢金柱, 翁鸿, 张超.经皮射频消融与微波消融治疗肝细胞癌有效性与安全性比较的Meta分析[J].临床肝胆病杂志, 2018, 34 (5) :1025-1035.
|
|
[13] CHEN S, ZHUANG WQ, GUO WB, et al. Feasibility and shortterm curative effect of CT-and ultrasound-guided microwave ablation of caudate lobe liver cancer[J]. Diagn Imag Interv Radiol, 2018, 27 (3) :219-225. (in Chinese) 陈嵩, 庄文权, 郭文波, 等. CT联合超声引导下经皮微波消融治疗尾状叶肝癌的可行性及短期疗效观察[J].影像诊断与介入放射学, 2018, 27 (3) :219-225.
|
|
[14] ZHOU HY, JING X, DING JM, et al. Analysis for complications of biliary tract after percutaneons thermal ablation for liver cancer[J].Chin J Ultrasonogr, 2016, 25 (11) :970-974. (in Chinese) 周洪雨, 经翔, 丁建民, 等.肝癌经皮热消融治疗后胆道并发症分析[J].中华超声影像学杂志, 2016, 25 (11) :970-974.
|
|
[15] TSUCHIYA N, SAWADA Y, ENDO I, et al. Potentiality of immunotherapy against hepatocellular carcinoma[J]. World J Gastroenterol, 2015, 21 (36) :10314-10326.
|
|
[16] HONG YP, LI ZD, PRASOON P, et al. Immunotherapy for hepatocellular carcinoma:From basic research to clinical use[J]. World J Gastroenterol, 2015, 7 (7) :980.
|
|
[17] HUANG ZM, LI W, LI S, et al. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients[J]. J Immunother, 2013, 36 (5) :287.
|
|
[18] WANG Z, WANG MD, LI ZL, et al. Immunotherapy for hepatocellular carcinoma:Research advances and clinical prospects[J].Acad J Second Military Med Univ, 2017, 38 (8) :953-960. (in Chinese) 王正, 王明达, 李镇利, 等.肝癌免疫治疗的研究进展和临床展望[J].第二军医大学学报, 2017, 38 (8) :953-960.
|
|
[19] TIAN ST, TONG Z, JIANG WQ, et al. Advances in immunotherapy of hepatocellular carcinoma[J/CD]. Chin J Transplant:Electronic edition, 2016, 10 (3) :138-140. (in chinese) 田淑婷, 童舟, 蒋微琴, 等.肝细胞肝癌免疫治疗研究进展[J/CD].中华移植杂志:电子版, 2016, 10 (3) :138-140.
|
|
[20] XU X, CHEN Y, ZHANG R, et al. Activation of anti-tumor immune response by ablation of HCC with nanosecond pulsed electric field[J]. J Clin Transl Hepatol, 2018, 6 (1) :85-88.
|
|
[21] REN ZG, CHEN XH, ZHOU L, et al. Research advances in the tumor ablation induced by nanosecond pulse[J]. Chin J Biomed Eng, 2014, 33 (5) :620-624. (in Chinese) 任志刚, 陈新华, 周琳, 等.纳秒脉冲肿瘤消融的研究进展[J].中国生物医学工程学报, 2014, 33 (5) :620-624.
|
|
[22] CHEN R, SAIN NM, HARLOW KT, et al. A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields[J]. Eur J Cancer Prev, 2014, 50 (15) :2705-2713.
|
|
[23] CHEN X, CHEN Y, JIANG J, et al. Nano-pulse stimulation (NPS) ablate tumors and inhibit lung metastasis on both canine spontaneous osteosarcoma and murine transplanted hepatocellular carcinoma with high metastatic potential[J]. Oncotarget, 2017, 8 (27) :44032-44039.
|
|
[24] CHEN X, YIN S, HU C, et al. Comparative study of nanosecond electric fields in vitro and in vivo on hepatocellular carcinoma indicate macrophage infiltration contribute to tumor ablation in vivo[J].PLo S One, 2014, 9 (1) :e86421.
|
|
[25] CHEN X, ZHUANG J, KOLB JF, et al. Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields[J]. Technol Cancer Res Treat, 2012, 11 (1) :83-93.
|
|
[26] CHATTERJEE S, BURNS TF. Targeting heat shock proteins in cancer:A promising therapeutic approach[J]. Int J Mol Sci, 2017, 18 (9) :1-39.
|
|
[27] ZHANG C. The expression and clinical significance of HSP70 in liver cancer[J]. China Modern Med, 2009, 16 (12) :62, 78. (in Chinese) 张晨.热休克蛋白70 (HSP70) 在肝癌中的表达及其临床意义[J].中国当代医药, 2009, 16 (12) :62, 78.
|
|
[28] ALDERSON TR, JIN HK, MARKLEY JL. Dynamical structures of Hsp70 and Hsp70-Hsp40 complexes[J]. Structure, 2016, 24 (7) :1014-1030.
|
|
[29] ZHAO Q, WANG XP. Heat shock protein 70 and hepatocellular carcinoma[J]. Basic Med Sci Clin, 2016, 36 (9) :1301-1305. (in Chinese) 赵倩, 王小平.热休克蛋白70与肝癌[J].基础医学与临床, 2016, 36 (9) :1301-1305.
|
|
[30] TAN JF, LYU MD, LIU DQ, et al. Effect of microwave ablation on cell activity and HSP70 expression of mouse liver cancer[J]. J Sun Yat-Sen Univ:Medical Sciences, 2006, 27 (4) :378-382. (in Chinese) 谭进富, 吕明德, 刘大全, 等.微波消融对小鼠肝癌细胞活性和HSP70表达的影响[J].中山大学学报:医学科学版, 2006, 27 (4) :378-382.
|
|
[31] MING WD, LI XG, JIN ZY. The impact and significance of HSP 70and IL-8 expresion before and after percutaneous radiofrequency ablation on rabbitleg VX2 tumor tissue[J]. J Med Imaging, 2016, 26 (8) :1517-1521. (in Chinese) 明韦迪, 李晓光, 金征宇.经皮射频消融兔小腿VX2肿瘤前后对组织HSP70、IL-8表达的影响及意义[J].医学影像学杂志, 2016, 26 (8) :1517-1521.
|
|
[32] DU MX, CHENG QS, WANG YJ, et al. Change of HSP70 expression in rabbit VX2 tumor before and after percutaneous radiofrequency ablation[J]. Pract J Cancer, 2003, 18 (6) :577-579. (in Chinese) 杜铭祥, 程庆书, 王云杰, 等.兔肺VX2肿瘤经皮射频消融术前后HSP70表达的改变[J].实用癌症杂志, 2003, 18 (6) :577-579.
|
|
[33] CHEN X, REN Z, YIN S, et al. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile[J]. Cytokine, 2017, 93:44-50.
|
|
[34] WU SL, PAN CE. Expression of HSP70 and MHC-I antigen in hepatocellular carcinoma and its significance[J]. World Chin J Dig, 2002, 10 (3) :291-294. (in Chinese) 吴胜利, 潘承恩.原发性肝癌HSP70与MHC-I类抗原表达的意义[J].世界华人消化杂志, 2002, 10 (3) :291-294.
|
|
[35] LI HM, ZHANG XL, HU PZ, et al. Expression and significance of P53 protein and heat shock protein 70 in hepatocellular carcinoma and adjacent liver tissue[J]. Shaanxi Med J, 2002, 31 (8) :681-683. (in Chinese) 李华民, 张晓丽, 胡沛臻, 等.肝癌及癌旁肝组织中P53蛋白及热休克蛋白70的表达及意义[J].陕西医学杂志, 2002, 31 (8) :681-683.
|
|
[36] WANG XP, LIU GZ, SONG AL, et al. Expression of heat shock protein 70 in human liver cancer tissue[J]. J Cap Univ Med Sci, 2004, 25 (2) :186-188. (in Chinese) 王小平, 刘国贞, 宋爱利, 等.人肝癌组织热休克蛋白70的表达[J].首都医科大学学报, 2004, 25 (2) :186-188.
|
|
[37] LIU N, XU J, LIU JH, et al. The Thl/Th2 cytokineslevelschangesofchronichepatitis, livercirrhosis, hepatitis B patients with hepatocellular carcinoma[J]. Chin J Gastroenterol Hepatol, 2014, 23 (2) :158-161. (in Chinese) 刘宁, 徐杰, 刘金花, 等.慢性乙型肝炎、乙肝肝硬化、乙肝肝癌患者Th1/Th2型细胞因子水平变化研究[J].胃肠病学和肝病学杂志, 2014, 23 (2) :158-161.
|
|
[38] HUANG M, WANG J, LEE P. Human non-small cell lung cancer cell express a type 2 cytokine pattern[J]. Cancer Res, 1995, 55 (17) :3847-3853.
|
|
[39] FU QG, MENG FD, GUO KJ, et al. Upregulating effect of tumorderiveed HSP70 to some THI type cytokines[J]. CHINA J Cancer Prve Treat, 2003, 10 (3) :250-252. (in Chinese) 傅庆国, 孟凡东, 郭克建, 等.肿瘤热休克蛋白70对几种Th1型细胞因子的诱升作用[J].中华肿瘤防治杂志, 2003, 10 (3) :250-252.
|
|
[40] CHUNG EJ, JEONG YI, LEE MR, et al. Heat shock proteins 70and 90 from Clonorchis sinensis, induce Th1 response and stimulate antibody production[J]. Parasit Vectors, 2017, 10 (1) :118.
|
|
[41] FU QG, MENG FD. The influence of tumor-derived heat shock protein 70 on the expression of Thl type cytokines of tumor-bearing mice[J]. Chin J Cancer Biother, 2002, 9 (2) :90-93. (in Chinese) 傅庆国, 孟凡东.肿瘤热休克蛋白70对荷瘤鼠Th1型细胞因子表达的影响[J].中国肿瘤生物治疗杂志, 2002, 9 (2) :90-93.
|
|
[42] CHEN XH, LI YJ, CAO XT, et al. Advances in the study of heat shock protein receptors[J]. Chin J Cancer Biother, 2002, 9 (2) :133-136. (in Chinese) 陈晓虹, 厉永建, 曹雪涛, 等.热休克蛋白受体的研究进展[J].中国肿瘤生物治疗杂志, 2002, 9 (2) :133-136.
|
|
[43] XIE Q, WANG JH, NIU B. ERAP and MHC-I molecular antigen presenting new progress[J]. Chin J Cell Mol Immunol, 2010, 26 (6) :619-621. (in Chinese) 谢秋, 王建华, 牛勃. ERAP与MHC-I类分子抗原提呈研究新进展[J].细胞与分子免疫学杂志, 2010, 26 (6) :619-621.
|
|
[44] TONG H, KANG YM, WANG XJ. HSP70 and tumor immunotherapy[J]. Acta Acad Med Nei Mongol, 2007, 29 (4) :297-301. (in Chinese) 佟豪, 康毅敏, 王晓娟. HSP70与肿瘤免疫治疗[J].内蒙古医科大学学报, 2007, 29 (4) :297-301.
|
|
[45] HUANG B, FENG ZH, ZHANG GM. Antitumor effect of DC vaccine modified by HSP70-H22 tumor peptide complex invitro and in vivo[J]. Chin J Immunol, 2002, 18 (9) :614-617. (in Chinese) 黄波, 冯作化, 张桂梅. Hsp70-肿瘤抗原肽复合物修饰的DC疫苗体内外特异性抗瘤作用[J].中国免疫学杂志, 2002, 18 (9) :614-617.
|
|
[46] CHEN RM, GONG FS, ZHEN QH, et al. Effect of TKD-activated NK cells on tumor growth inhibition of humanpancreatic carcinoma in nude mice[J]. Chin J Immunol, 2015, 31 (12) :1605-1609. (in Chinese) 陈蓉明, 龚福生, 郑秋红, 等. HSP70-TKD诱导的NK细胞对胰腺癌细胞裸鼠移植瘤的抑制作用[J].中国免疫学杂志, 2015, 31 (12) :1605-1609.
|
|
[47] LIU YX, YU H, ZHANG ZW, et al. Experimental study on the effect of heat shock protein 70 on the anti-liver cancer of dendritic cells[J]. Chin J Lab Diagn, 2010, 12 (14) :1969-1971. (in Chinese) 刘玉侠, 于鸿, 张振武, 等.热休克蛋白70激发树突状细胞抗肝癌作用的实验研究[J].中国实验诊断学, 2010, 12 (14) :1969-1971.
|
|
[48] ZHANG YY, WANG LB, ZHAO Q, et al. Advanced research on relationship between tumor microenvironment and radiosensitivity of tumor cells[J]. J Jilin Univ:Med Edit, 2016, 42 (5) :1038-1044. (in Chinese) 张玉宇, 王利波, 赵钦, 等.肿瘤微环境与肿瘤细胞放射敏感性关系的研究进展[J].吉林大学学报:医学版, 2016, 42 (5) :1038-1044.
|
DownLoad: